These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. [Toll-like receptors and the significance for clinical medicine]. Wiersinga WJ, van der Poll T. Ned Tijdschr Geneeskd; 2005 May 21; 149(21):1150-5. PubMed ID: 15940918 [Abstract] [Full Text] [Related]
31. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. O'Neill LA. Immunol Rev; 2008 Dec 21; 226():10-8. PubMed ID: 19161412 [Abstract] [Full Text] [Related]
32. A comprehensive map of the toll-like receptor signaling network. Oda K, Kitano H. Mol Syst Biol; 2006 Dec 21; 2():2006.0015. PubMed ID: 16738560 [Abstract] [Full Text] [Related]
33. Toll-like receptors and immune regulation: implications for cancer therapy. Wang RF, Miyahara Y, Wang HY. Oncogene; 2008 Jan 07; 27(2):181-9. PubMed ID: 18176599 [Abstract] [Full Text] [Related]
34. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages. Hall C, Flores MV, Chien A, Davidson A, Crosier K, Crosier P. J Leukoc Biol; 2009 May 07; 85(5):751-65. PubMed ID: 19218482 [Abstract] [Full Text] [Related]
35. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Lee JK, Kim SY, Kim YS, Lee WH, Hwang DH, Lee JY. Biochem Pharmacol; 2009 Apr 15; 77(8):1391-400. PubMed ID: 19426678 [Abstract] [Full Text] [Related]
38. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. Albiger B, Dahlberg S, Henriques-Normark B, Normark S. J Intern Med; 2007 Jun 15; 261(6):511-28. PubMed ID: 17547708 [Abstract] [Full Text] [Related]